author={Kyle A. Weant and John A. Armitstead and Alim Ladha and Deanna M. Sasaki-Adams and Eldad Hadar and Matthew G. Ewend},
OBJECTIVEIn 1999, the Society of Critical Care Medicine formally recognized that pharmacists were essential for the provision of high quality care to the critically ill population. This study is a brief quantitative analysis of the benefit provided by a clinical pharmacist in a multidisciplinary neurosurgical setting. METHODSPatients admitted to the neurosurgical service in the 2 years before and 2 years after the implementation of dedicated neurosurgical pharmacy services were retrospectively… 

Figures and Tables from this paper

Impact of clinical pharmacist in an Indian Intensive Care Unit

Clinical pharmacist as a part of multidisciplinary team in an Indian Intensive Care Unit was associated with a substantially lower rate of adverse drug event caused by medication errors, drug interactions, and drug incompatibilities.

[Feedback on the evaluation of clinical pharmacy activities developed in surgery].

Interdisciplinary Patient Care in the Intensive Care Unit: Focus on the Pharmacist

Although there is still room for improvement in the range of pharmacist involvement, particularly with respect to interdisciplinary activities related to education and scholarship, pharmacists have become essential members of interdisciplinary care teams in ICU settings.

Outcome Assessment of Critical Care Pharmacist Services

The goal of this commentary is to briefly outline the value of critical care pharmacy services through the years, with an emphasis on the possibilities for the future.

Implementing the Use of Pharmacist Progress Notes in a Surgical ICU

It is demonstrated that the implementation of daily pharmacist progress notes is feasible in an advanced practice setting, and the pharmacist's contribution to patient care may be obtained through review of this documentation in the patient's medical record.

Outcomes of expanded use of clinical pharmacist practitioners in addition to team-based care in a community health system intensive care unit.

  • E. MichaletsJulie CregerW. Shillinglaw
  • Medicine, Political Science
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2015
With expanded CPP involvement on the NTICU team, there was a substantial increase in therapeutic optimization interventions and a clinically notable reduction in preventable ADEs, as well as an estimated 30% increase in associated cost savings.

Impact of Quality Bundle Enforcement by a Critical Care Pharmacist on Patient Outcome and Costs*

Critical care pharmacist-led interventions were associated with decreases in ICU and hospital length of stays and ICU drug costs and no impact on mortality rate was identified.

Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases

Clinical pharmacists’ interventions assisted in early detection of drug problems and prevention of the consequent patient harms and Poisson regression of factors that may influence the frequency of DRPs revealed significant associations of patient age and the number of comorbid diseases.

Pharmacotherapy in the Neurosurgical Intensive Care Unit

An understanding of the basic pharmacodynamic and pharmacokinetic characteristics of medications is paramount in the management of the critically ill neuroscience patient. Furthermore, the influence

Development of Clinical Pharmacy services at King Khalid University Hospital and its impact on the quality of healthcare provided.

  • A. Saddique
  • Medicine, Political Science
    Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
  • 2012



Intensive care unit antimicrobial resistance and the role of the pharmacist

This review will address the many issues that surround the appropriate use of antibiotics and what role the pharmacist can play in ensuring the optimal use of infection control measures in the ICU and hospital.

National survey of critical-care pharmaceutical services.

The level of clinical and educational services provided to critical-care patients was significantly lower for intensive-care unit (ICU) pharmacists practicing in satellite pharmacies than it was for ICU pharmacists not associated with satellite pharmacies.

A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.

These interventions had no impact on length of hospital stay, in-hospital mortality, 30-day readmissions, or the need to readminister the targeted medication or restart intravenous therapy.

Medication Dosing and Renal Insufficiency in a Pediatric Cardiac Intensive Care Unit: Impact of Pharmacist Consultation

Patients who required medication adjustment for renal dysfunction were significantly younger compared to those patients not requiring medication adjustment, and the monetary impact of pharmacist interventions, in doses saved, was approximately $12,000.

Posthospital medication discrepancies: prevalence and contributing factors.

A significant percentage of older patients experienced medication discrepancies after making the transition from hospital to home, and both patient-associated and system-associated solutions may be needed to ensure medication safety during this vulnerable period.

The impact of critical care pharmacists on enhancing patient outcomes

The purpose of this article is to review the literature pertaining to pharmacists' contributions within a multidisciplinary intensivist-led intensive care unit (ICU) team.

Critical Care Pharmacy Services in United States Hospitals

Clinical pharmacists are directly involved as caregivers in nearly two-thirds of ICUs in the US, and although they provide a range of clinical and administrative services, involvement in educational and scholarly activities is variable.

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.

The presence of a pharmacist on rounds as a full member of the patient care team in a medical ICU was associated with a substantially lower rate of ADEs caused by prescribing errors.

Clinical Pharmacy Services and Hospital Mortality Rates

This is the first study to indicate that both centrally based and patient‐specific clinical pharmacy services are associated with reduced hospital mortality rates, and suggests that these services save a significant number of lives in the authors' nation's hospitals.

Impact of Therapeutic Drug Monitoring of Intravenous Theophylline Regimens on Serum Theophylline Concentrations in the Medical Intensive Care Unit

Pharmacokinetic analysis when performing TDM in the determination of intravenous theophylline regimens can result in optimal therapy for patients, while significantly reducing the number of STCs required.